Immune modulatory vaccines: the safe way to inflame the tumor microenvironment & guide anti-cancer immunotherapies

Immuno-Oncology Insights 2022; 3(9), 401–407

DOI: 10.18609/ioi.2022.043

Published: 13 October 2022
Mads Hald Andersen

“Mapping the cell types and molecules present in the inimical tumor milieu will support the development of more effective IMVs and teach us how best to combine the current available options.”